| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $270 | — | -2.5% |
| SG&A Expense | $47K | — | -46.6% |
| Net Income | -$62K | — | +39.7% |
| EPS (Basic) | $0.00 | — | — |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $17K | +77.0% | +105.8% |
| Total Assets | $36K | +11.5% | -17.8% |
| Current Liabilities | $829K | +7.7% | +49.0% |
| Stockholders' Equity | -$793K | -7.5% | -54.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $734 | — | +122.3% |